Browsing Tag
Medical Devices
27 posts
Why Science Corporation’s ecosystem deal with Neurosoft Bioelectronics could reshape how brain interfaces scale
Science Corporation’s BCI ecosystem deal with Neurosoft Bioelectronics hints at a platform shift in brain-computer interfaces. Read why this matters now.
What Medtronic’s Stealth AXiS FDA clearance signals for surgical navigation and robotics competition
Medtronic has secured FDA clearance for Stealth AXiS. Find out how this move strengthens its surgical navigation strategy and long-term competitive position.
IceCure Medical Ltd confirms departure of CFO Ronen Tsimerman amid funding and growth scrutiny
IceCure Medical Ltd confirms CFO Ronen Tsimerman’s departure. Find out what the leadership shift signals for strategy, capital discipline, and investors.
Keysight Technologies (NYSE: KEYS) launches wireless coexistence test platform for FDA-compliant devices
Keysight launches an automated RF coexistence test platform to help engineers meet ANSI C63.27 and FDA guidance. Find out what it means for the sector.
Soin Neuroscience and BIOTRONIK Neuro target SCS personalization with novel waveform collaboration
Find out how Soin Neuroscience and BIOTRONIK Neuro are using adaptive waveforms to personalize spinal cord stimulation therapy for chronic pain.
RemeOs DrillPin designation boosts Bioretec’s U.S. regulatory momentum in bioresorbable implants
Find out how Bioretec’s FDA Breakthrough Device Designation for its RemeOs DrillPin may reshape U.S. orthopedic fracture care and support its strategic ambitions.
Why Alcon raised its bid for STAAR Surgical and dropped matching rights in amended merger deal
Find out how Alcon raised its cash bid for STAAR Surgical and removed matching rights to secure a $1.6 billion refractive-technology acquisition.
Can Hugo give hospitals a smarter surgical robot? FDA clearance puts Medtronic to test
Medtronic gets U.S. FDA clearance for Hugo RAS system in urologic surgery, unlocking new competition in robotic-assisted soft-tissue procedures. Read more.
Why U.S. based Trividia Health is gaining traction in blood glucose testing with TRUE METRIX
Trividia Health’s TRUE METRIX devices join Express Scripts’ preferred formulary. Discover how this U.S.-made glucose monitor is changing diabetes care access.
GE HealthCare’s $2.3bn Intelerad acquisition boosts SaaS ambitions and lifts investor sentiment
GE HealthCare to acquire Intelerad for $2.3B to scale SaaS imaging across care settings. Explore what this means for investors and the AI roadmap.